Denmark· DK-28107189624
Rezolsta
A darunavir and cobicistat product containing cobicistat, darunavirethanolat, registered in Denmark by Janssen-Cilag International NV. The same ATC class is registered in 12 of our 19 countries.
Checked against Danish Medicines Agency (Denmark) on
Informational only — not a medical device.
Where it is registered
Darunavir and cobicistat is registered in 12 of 19 countries.
Countries holding a registration under ATC J05AR14 (darunavir and cobicistat), each read from that country’s own register.
- This record: Denmark, from Danish Medicines Agency (Denmark)
- 7 of them publish a price we can compare per daily dose
Darunavir and cobicistat · ATC J05AR14
12 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- United Kingdom
The record
At a glance
Danish Medicines Agency (Denmark)- Active substance
- Cobicistat, Darunavirethanolat
- Manufacturer
- Janssen-Cilag International NV
- Country
- Denmark (DK)
- ATC code
- J05AR14
- ATC class
- Darunavir and cobicistat
- Reimbursed
- Not published by this register
- Source register
- Danish Medicines Agency (Denmark)
- Last checked
- September 30, 2026
Packs & prices · 1
- dk_varenummer28107189624
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
541 interactions on record for darunavir and cobicistat.
Graded by severity as the source publishes them — 243 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Darunavir and cobicistat · interactions on record
541 records
- 243 severe
- 277 moderate
- 21 minor
Most severe, free to view
- CisaprideA03FA02severe
- NaloxegolA06AH03severe
- LoperamideA07DA03severe
- EluxadolineA07DA06severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under J05AR14
Darunavir and cobicistat, as other registers publish it.
- CanadaPREZCOBIXJANSSEN INC
- NorwayRezolstaJanssen-Cilag International N.V.
- DenmarkRezolstaJanssen-Cilag International NV
- PolandRezolstaJanssen-Cilag International N.V.
- DenmarkRezolstaJanssen-Cilag International NV
- FinlandREZOLSTAJanssen-Cilag International NV
- FinlandREZOLSTAParanova Oy
- CzechiaREZOLSTAJanssen-Cilag International N.V., Beerse
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/192a2e71-7916-4792-ba80-5a196239fd17 GET /v1/drugs/192a2e71-7916-4792-ba80-5a196239fd17?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "filmovertrukne tabletter",
"source": "dkma",
"strength": "675 mg + 150 mg",
"auth_role": "MOD",
"dk_drugid": "28107189624",
"substance": "Cobicistat, Darunavirethanolat",
"auth_procedure": "Central",
"in_medicinpriser": false,
"registration_date_serial": "41962"
}See everything about darunavir and cobicistat.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.